Kenneth Londoner - Sep 1, 2021 Form 4 Insider Report for BioSig Technologies, Inc. (BSGM)

Role
Chief Executive Officer, Director
Signature
/s/ Kenneth L. Londoner, attorney-in-fact
Stock symbol
BSGM
Transactions as of
Sep 1, 2021
Transactions value $
$17,337
Form type
4
Date filed
9/2/2021, 12:56 PM
Previous filing
Aug 31, 2021
Next filing
Sep 29, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSGM Common Stock Purchase $13.6K +4.4K +0.26% $3.10* 1.71M Sep 1, 2021 Direct F1
transaction BSGM Common Stock Purchase $3.71K +1.2K +0.07% $3.09* 1.71M Sep 2, 2021 Direct F2
holding BSGM Common Stock 1.18M Sep 1, 2021 By Endicott Management Partners, LLC F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.09 to $3.097, inclusive. The reporting person undertakes to provide to BioSig Technologies, Inc., any security holder of BioSig Technologies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
F2 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.07 to $3.22, inclusive.
F3 The Reporting Person is the beneficial owner of Endicott Management Partners, LLC.